Searched for
TRIZIVIR
Sun shines in pharma space; M-cap greater than DRL, Lupin, Cipla & Ranbaxy combinedThe market capitalisation of Sun Pharmaceuticals exceeded that of Dr Reddy's, Lupin, Cipal and Ranbaxy Laboratories combined on Wednesday, ...- Indian drugmakers switching to fresh strategies as US amends normsIndian generic drug producers are devising fresh strategies to continue benefiting from the world’s largest pharmaceutical market the Unite...
- Lupin: US launches, better movement of rupee add valueDrugmaker Lupin’s performance in the quarter to December indicates a better showing by the company in the second half of the current fiscal.
- Lupin's earnings outperform Street expectations, to stay our top pick: Kirit Gogri, Quant Broking"The US business has been a big game changer for Lupin and I am presuming that the US business would have delivered much superior numbers t...
- Dr. Reddy’s & Sun Pharma to see strong Q3 earnings growth: Arvind Bothra, Religare"Lupin would have a stable revenue growth merely because some of the recent launches that they have had have been in the latter part of the...
- Lupin launches HIV drug in the US with marketing exclusivityLupin launched the generic version of ViiV Healthcare's Trizivir tablets in the US market with 180-days of marketing exclusivity.
- Several Indian companies get FDA nod for anti-depressant drugThe US Food and Drug Administration has approved the first generic versions of Cymbalta, a prescription medicine used in treatment of depre...
- Lupin gets USFDA nod to market HIV drug in the US marketThe company's product is indicated in combination with other antiretrovirals or alone for the treatment of HIV-1 infection, it added.
- Patenting gets tough, rightlyThree years ago when drug makers in India saw the possibility of their product basket drying up due to changes in the law meant to give mar...
- GSK drops claims on two AIDS medicinesIn a relief to around 2.5 million HIV patients and generic firms like Cipla and Ranbaxy, GlaxosmithKline (GSK) has pulled out the patent ap...
Load More
